Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.66%
#2 aelf aelf +22.92%
#3 Venom Venom +18.48%
#4 TRIA TRIA +10.74%
#5 Pons Pons +10.08%
#6 Decred Decred +9.66%
#7 Wibx Wibx +8.10%
#8 DexNet DexNet +7.56%
#9 Janction Janction +7.42%
#10 Bitway Bitway +6.88%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Aelis Farma S.A. Aelis Farma S.A.

Aelis Farma S.A.

AELIS
Rangering i aksjer #30387
Aelis Farma S.A., a French biotechnology company founded in 2013 and... Aelis Farma S.A., a French biotechnology company founded in 2013 and headquartered in Bordeaux, is dedicated to the discovery and development of treatments for brain-related illnesses. The firm's research pipeline primarily focuses on signaling-specific inhibitors that target CB1 receptors. Its leading investigational drug, AEF0117, is currently advancing through Phase 2b clinical trials, designed to alleviate the harmful impacts of excessive cannabis consumption. Furthermore, AEF0217, another key drug candidate, has successfully completed Phase 1 clinical trials, with the goal of addressing cognitive impairments linked to Down syndrome and other similar conditions.
Aksjekurs
$1.25
Sist synkronisert: 2026-08-18
Markedsverdi
$17.05M
Endring (1 dag)
-1.50%
Endring (1 år)
-22.24%
Land
FR
Handel Aelis Farma S.A. (AELIS)

Kategori

Healthcare
Aksjeprishistorikk for Aelis Farma S.A. (AELIS)
Høyeste sluttskurs: $1.25 den 2026-08-01

Laveste sluttskurs: $14.72 den 2022-02-01
Aksjeprishistorikk for Aelis Farma S.A. fra 2022 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) 10.37%
2025 -46.69%
2024 -83.48%
2023 20.47%
2022 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $527.89 35.09%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $996.61 51.72%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $116.54 -19.94%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $735.86 6.07%
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $257.75 14.92%
BE